CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 
The search for a definitive cure for cancer continues, and thanks to the advancements in technology and scientific discoveries, we are able to make some progress in cancer treatments. A recent report reveals that scientists are looking into the hidden potential of liquid biopsies in cancer prevention.
Although liquid biopsies, when it comes to determining the presence of cancer cells, are something that has been done for a while, scientists believe that, with more fine-tuning, this method may be done to detect cancer before it spreads or even begins. Liquid biopsies are essentially blood tests, where doctors look for cancer cells that may already be present in the blood or for the presence of DNA from tumor cells that are already in the blood.
Liquid biopsies are already being done for certain types of cancer, such as prostate, ovarian, and even lung cancer. Another advantage of this type of biopsy is that it is non-invasive and can be repeated not just to make sure if it is positive or negative. It can be repeated for doctors to be able to study the tumor in real-time as well. There will not be a need for invasive methods like colonoscopies, mammograms, x-rays, CT scans, and the like as all the information can all be taken from a simple blood test.
Meanwhile, for those who suffer from prostate cancer, some scientists may have discovered a plant with properties that can potentially be useful in cancer treatment. The plant is from Pakistan, with the scientific name Withania Coagulans and is actually being used in the herbal treatment of many ailments from migraines to fertility. Farmers also use this plant in order to coagulate cheese. The kernels from this plant are also used to treat diabetes.
So it bears wondering if the plant can also be able to help treat cancer, specifically prostate cancer. In a series of studies regarding this possibility, researchers have discovered that the secondary compounds found in the plant called withanolides, seem to be able to slow down the growth and mobility in prostate cancer cells. This would become a new breakthrough in treating the disease, which affects a lot of men in the world.
According to one of the researchers, Ken Keefover-Ring, this has given them more understanding of the kinds of compounds that can beat cancer. However, he also said that this does not necessarily mean this will become the next drug, even if it appears to be the case.
